Pgc-1, a novel brown fat ppar.gamma. coactivator
CA 2353086 C · Owner: Wu, Zhidan · Inventors: Puigserver, Pere; Spiegelman, Bruce M.; Wu, Zhidan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides isolated nucleic acids molecules designated PGC-1 , nucleic acid molecules which encode proteins which can modulate various adipocyte-associated activities including for example, thermogenesis in , adipocytes e.g. brown adipocytes, and adipogenesis. The invention also provides antisense nucleic acid molecules recombinant expression vectors , containing PGC-1 nucleic acid molecules host cells into which the expression , vectors have been introduced and nonhuman transgenic animals in which a PGC-1 gene has been introduced or disrupted. The invention still further provides isolated PGC-1 proteins, fusion proteins antigenic peptides and anti-PGC-1 , antibodies. …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 30, 1999 and granted April 10, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 30, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 30, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.